208 related articles for article (PubMed ID: 26216825)
1. Reoperative Retroperitoneal Surgery: Etiology and Clinical Outcome.
Woldu SL; McKiernan JM
Urol Clin North Am; 2015 Aug; 42(3):381-92. PubMed ID: 26216825
[TBL] [Abstract][Full Text] [Related]
2. Reoperative retroperitoneal surgery.
Sheinfeld J; Sogani P
Urol Clin North Am; 2007 May; 34(2):227-33; abstract x. PubMed ID: 17484927
[TBL] [Abstract][Full Text] [Related]
3. Repeat retroperitoneal lymph node dissection for metastatic testis cancer.
Sexton WJ; Wood CG; Kim R; Pisters LL
J Urol; 2003 Apr; 169(4):1353-6. PubMed ID: 12629359
[TBL] [Abstract][Full Text] [Related]
4. Reoperative retroperitoneal lymph node dissection for metastatic germ cell tumors: analysis of local recurrence and predictors of survival.
Pedrosa JA; Masterson TA; Rice KR; Bihrle R; Beck SD; Foster RS
J Urol; 2014 Jun; 191(6):1777-82. PubMed ID: 24518787
[TBL] [Abstract][Full Text] [Related]
5. Repeat retroperitoneal lymph-node dissection after chemotherapy for metastatic testicular germ cell tumour.
Willis SF; Winkler M; Savage P; Seckl MJ; Christmas TJ
BJU Int; 2007 Oct; 100(4):809-12. PubMed ID: 17711512
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection.
Djaladat H; Nichols C; Daneshmand S
Ann Surg Oncol; 2012 Jul; 19(7):2388-93. PubMed ID: 22395993
[TBL] [Abstract][Full Text] [Related]
7. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP
BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110
[TBL] [Abstract][Full Text] [Related]
8. Robotic Assisted Retroperitoneal Lymph Node Dissection for Small Volume Metastatic Testicular Cancer.
Hiester A; Nini A; Arsov C; Buddensieck C; Albers P
J Urol; 2020 Dec; 204(6):1242-1248. PubMed ID: 32717162
[TBL] [Abstract][Full Text] [Related]
9. Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer.
Calaway AC; Einhorn LH; Masterson TA; Foster RS; Cary C
Eur Urol; 2019 Nov; 76(5):607-609. PubMed ID: 31174891
[TBL] [Abstract][Full Text] [Related]
10. The role of lymphadenectomy for testicular cancer: indications, controversies, and complications.
Tarin T; Carver B; Sheinfeld J
Urol Clin North Am; 2011 Nov; 38(4):439-49, vi. PubMed ID: 22045175
[TBL] [Abstract][Full Text] [Related]
11. Contemporary management of postchemotherapy testis cancer.
Daneshmand S; Albers P; Fosså SD; Heidenreich A; Kollmannsberger C; Krege S; Nichols C; Oldenburg J; Wood L
Eur Urol; 2012 Nov; 62(5):867-76. PubMed ID: 22938868
[TBL] [Abstract][Full Text] [Related]
12. Minimally Invasive Retroperitoneal Lymphadenectomy: Current Status.
Kunit T; Janetschek G
Urol Clin North Am; 2015 Aug; 42(3):321-9. PubMed ID: 26216819
[TBL] [Abstract][Full Text] [Related]
13. Reoperative retroperitoneal lymph-node dissection for testicular germ cell tumor.
Murphy AM; McKiernan JM
World J Urol; 2009 Aug; 27(4):501-6. PubMed ID: 19636565
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic retroperitoneal lymph node dissection for low-stage cancer: a Washington University update.
Gardner MW; Roytman TM; Chen C; Brandes SB; Kibel AS; Grubb RL; Bhayani SB; Figenshau RS
J Endourol; 2011 Nov; 25(11):1753-7. PubMed ID: 21936630
[TBL] [Abstract][Full Text] [Related]
15. [Post-chemotherapy laparoscopic retroperitoneal lymph node dissection in low volume residual germ cell cancer: a technique to reduce morbidity].
Aufderklamm S; Todenhöfer T; Hennenlotter J; Gakis G; Mischinger J; Mundhenk J; Germann M; Stenzl A; Schwentner C
Urologe A; 2013 Aug; 52(8):1097-103. PubMed ID: 23416965
[TBL] [Abstract][Full Text] [Related]
16. Retroperitoneal lymph node dissection in testicular cancer.
Jacobsen NE; Foster RS; Donohue JP
Surg Oncol Clin N Am; 2007 Jan; 16(1):199-220. PubMed ID: 17336244
[TBL] [Abstract][Full Text] [Related]
17. Retroperitoneal lymph node dissection in patients with high risk testicular cancer.
Williams SB; McDermott DW; Dock W; Bahnson E; Berry AM; Steele GS; Richie JP
J Urol; 2009 May; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227
[TBL] [Abstract][Full Text] [Related]
18. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma.
Carver BS; Shayegan B; Serio A; Motzer RJ; Bosl GJ; Sheinfeld J
J Clin Oncol; 2007 Mar; 25(9):1033-7. PubMed ID: 17261854
[TBL] [Abstract][Full Text] [Related]
19. The Role of Postchemotherapy Surgery in Germ Cell Tumors.
Chéry L; Dash A
Urol Clin North Am; 2015 Aug; 42(3):331-42. PubMed ID: 26216820
[TBL] [Abstract][Full Text] [Related]
20. Desperation Postchemotherapy Retroperitoneal Lymph Node Dissection for Metastatic Germ Cell Tumors.
Carver BS
Urol Clin North Am; 2015 Aug; 42(3):343-6. PubMed ID: 26216821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]